Antimicrobial Resistance News and Research

RSS

Study: Over 3 million children died in 2022 due to drug-resistant infections

A landmark study presented today at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.

12 Apr 2025

RSV-associated infections linked to higher one year mortality in adults

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death within one year compared to the general population.

11 Apr 2025

IL-6 emerges as early sepsis indicator in high risk groups

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women.

11 Apr 2025

Cholera cases in Europe linked to holy water imported from Ethiopia

Consumption of holy water from Ethiopia has recently led to several cases of cholera in Germany and the United Kingdom (UK) with a multidrug-resistant Vibrio cholerae strain, according to a study published in Eurosurveillance.

10 Apr 2025

New antibiotic compound emerges as strong candidate in the fight against MRSA

The development of new antibiotics to treat superbugs and other bacterial infections is a global priority, with the rate of infections that cannot be treated with current antibiotics rising and presenting one of the biggest threats to human health.

10 Apr 2025

National Quantum Computing Centre launches Insights Paper exploring quantum computing's transformative potential in healthcare and pharmaceuticals

Today, the National Quantum Computing Centre (NQCC) launched its first Insights Paper, "The convergence of healthcare and pharmaceuticals with quantum computing: A new fronter in medicine", exploring how quantum computing could enable a step-change in medicine and healthcare delivery over the coming decades.

From NQCC 4 Apr 2025

New bacterial evolutionary map could lead to precision treatments for infections

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for certain antibiotic-resistant infections, such as urinary tract infections.

3 Apr 2025

Study exposes huge levels untargeted antibiotic prescribing

Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of prognosis and the risk of the infection worsening, according to a new study led by University of Manchester epidemiologists.

3 Apr 2025

New drug strategy targets Staphylococcus aureus toxin to treat pneumonia

Pneumonia caused by the bacterium Staphylococcus aureus is one of the most dangerous infections that can occur in hospital.

2 Apr 2025

WHO releases first reports on shortages in fungal disease treatments and diagnostics

The World Health Organization (WHO) today published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for innovative research and development (R&D) to close these gaps.

2 Apr 2025

Breakthrough discovery could lead to new class of antibiotics

The last time a new class of antibiotics reached the market was nearly three decades ago - but that could soon change, thanks to a discovery by researchers at McMaster University.

26 Mar 2025

Global analysis of antimicrobial resistance in Campylobacter

Announcing a new article publication for Zoonoses journal. The zoonotic pathogen Campylobacter is a major foodborne bacterial species worldwide. The distribution and drivers of antimicrobial resistance (AMR) in global Campylobacter strains remain largely unknown. Therefore, a comprehensive analysis of longitudinal trends and driving factors of AMR in Campylobacter is necessary at a global level.

26 Mar 2025

Four breakthrough studies could revolutionize tuberculosis treatment

As of early 2025, tuberculosis cases are increasing in the U.S. This disease, often shortened to TB, causes significant lung damage and, if not treated, is almost always lethal.

22 Mar 2025

Study reveals trends in drug-resistant Campylobacter infections across the U.S.

Campylobacter infections are the most common foodborne illnesses in the U.S., sickening an estimated 1.5 million people each year.

19 Mar 2025

Researchers explore H. pylori treatment policies in the Asia-Pacific region

Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high in the Asia-Pacific region.

19 Mar 2025

FDA-approved drug for chronic kidney disease may help mitigate antibiotic resistance

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment.

18 Mar 2025

Identifying genetic resistance factors and antimicrobial resistance phenotypes in MRSA strains

With the rising prevalence of methicillin-resistant Staphylococcus (S.) aureus (MRSA), a multi drug resistant strain, treatment has become a challenge.

18 Mar 2025

Microplastics found to promote antibiotic resistance in bacteria

Microplastics-tiny shards of plastic debris-are all over the planet. They have made their way up food chains, accumulated in oceans, clustered in clouds and on mountains, and been found inside our bodies at alarming rates.

11 Mar 2025

Randomized clinical food trials: Best clinical practice, quality management & data processing

The evolution of food clinical trials highlights the importance of quality management and ICH-GCP adherence in validating health claims and interventions.

From Atlantia Clinical Trials 28 Feb 2025

Staffing reductions in U.S. health agencies threaten public health

Staffing reductions across U.S. federal health agencies-including the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), and Agency for Healthcare Research and Quality (AHRQ)-pose a significant threat to public health, according to the Society for Healthcare Epidemiology of America (SHEA).

19 Feb 2025